Pharmaceutical Manufacturing Handbook: Production and

762 OCULAR DRUG DELIVERY
139. Maestrelli , F. , Mura , P. , Casini , A. , Mincione , F. , Scozzafava , A. , and Supuran , C. T. ( 2002 ),
Cyclodextrin complexes of sulfonamide carbonic anhydrase inhibitors as long - lasting
topically acting antiglaucoma agents , J. Pharm. Sci. , 91 ( 10 ), 2211 – 2219 .
140. Nijhawan , R. , and Agarwal , S. P. ( 2003 ), Development of an ophthalmic formulation
containing ciprofl oxacin - hydroxypropyl - β - cyclodextrin complex , Boll. Chim. Farm. ,
142 ( 5 ), 214 – 219 .
141. Aktas , Y. , Unlu , N. , Orhan , M. , Irkec , M. , and Hincal , A. A. ( 2003 ), Infl uence of hydroxypropyl
beta - cyclodextrin on the corneal permeation of pilocarpine , Drug Dev. Ind.
Pharm. , 29 ( 2 ), 223 – 230 .
142. Harwood , R. J. , and Schwartz , J. B. ( 1982 ), Drug release from compression molded fi lms:
Preliminary studies with pilocarpine , Drug Dev. Ind. Pharm. , 8 ( 5 ), 663 – 682 .
143. Hsiue , G. H. , Guu , J. A. , and Cheng , C. C. ( 2001 ), Poly(2 - hydroxyethyl methacrylate) fi lm
as a drug delivery system for pilocarpine , Biomaterials , 22 ( 13 ), 1763 – 1769 .
144. Bharath , S. , and Hiremath , S. R. ( 1999 ), Ocular delivery systems of pefl oxacin mesylate ,
Pharmazie , 54 ( 1 ), 55 – 58 .
145. Sultana , Y. , Aqil , M. , and Ali , A. ( 2005 ), Ocular inserts for controlled delivery of pefl oxacin
mesylate: Preparation and evaluation , Acta Pharma. , 55 ( 3 ), 305 – 314 .
146. Zimmermann , C. , Drewe , J. , Flammer , J. , and Shaarawy , T. ( 2004 ), In vitro release of
mitomycin C from collagen implants , Curr. Eye Res. , 28 ( 1 ), 1 – 4 .
147. Vasantha , V. , Sehgal , P. K. , and Rao , K. P. ( 1988 ), Collagen ophthalmic inserts for pilocarpine
drug delivery system , Int. J. Pharm. , 47 ( 1 – 3 ), 95 – 102 .
148. Saettone , M. F. , Giannaccini , B. , Chetoni , P. , Galli , G. , and Chiellini , E. ( 1984 ), Vehicle
effects in ophthalmic bioavailability: An evaluation of polymeric inserts containing
pilocarpine , J. Pharm. Pharmacol. , 36 ( 4 ), 229 – 234 .
149. Saettone , M. F. , Torracca , M. T. , Pagano , A. , Giannaccini , B. , Rodriguez , L. , and Cini , M.
( 1992 ), Controlled release of pilocarpine from coated polymeric ophthalmic inserts
prepared by extrusion , Int. J. Pharm. , 86 ( 2 – 3 ), 159 – 166 .
150. Saettone , M. F. , Chetoni , P. , Bianchi , L. M. , Giannaccini , B. , Conte , U. , and Sangalli , M.
E. ( 1995 ), Controlled release of timolol maleate from coated ophthalmic mini - tablets
prepared by compression , Int. J. Pharm. , 126 (1 – 2 ), 79 – 82 .
151. Sasaki , H. , Tei , C. , Nishida , K. , and Nakamura , J. ( 1993 ), Drug release from an ophthalmic
insert of a beta - blocker as an ocular drug delivery system , J. Controlled Release , 27 ( 2 ),
127 – 137 .
152. Sasaki , H. , Nagano , T. , Sakanaka , K. , Kawakami , S. , Nishida , K. , Nakamura , J. , et al.
( 2003 ), One - side - coated insert as a unique ophthalmic drug delivery system , J. Controlled
Release , 92 ( 3 ), 241 – 247 .
153. Charoo , N. A. , Kohli , K. , Ali , A. , and Anwer , A. ( 2003 ), Ophthalmic delivery of ciprofl
oxacin hydrochloride from different polymer formulations: In vitro and in vivo studies ,
Drug Dev. Ind. Pharm. , 29 ( 2 ), 215 – 221 .
154. Pijls , R. T. , Sonderkamp , T. , Daube , G. W. , Krebber , R. , Hanssen , H. H. L. , Nuijts , R. M.
M. A. , et al. ( 2005 ), Studies on a new device for drug delivery to the eye , Eur. J. Pharm.
Biopharm. , 59 ( 2 ), 283 – 288 .
155. Lux , A. , Maier , S. , Dinslage , S. , Suverkrup , R. , and Diestelhorst , M. ( 2003 ), A comparative
bioavailability study of three conventional eye drops versus a single lyophilisate , Br. J.
Ophthalmol. , 87 ( 4 ), 436 – 440 .
156. Dinslage , S. , Diestelhorst , M. , Weichselbaum , A. , and Suverkrup , R. ( 2002 ), Lyophilisates
for drug delivery in Ophthalmology: Pharmacokinetics of fl uorescein in the human
anterior segment , Br. J. Ophthalmol. , 86 ( 10 ), 1114 – 1117 .
157. Ceulemans , J. , Vermeire , A. , Adriaens , E. , Remon , J. P. , and Ludwig , A. ( 2001 ), Evaluation
of a mucoadhesive tablet for ocular use , J. Controlled Release , 77 ( 3 ), 333 – 344 .